Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
the AMBER portal (including CV and detailed research plan), and finally, strict compliance with the MSCA mobility rule that the researcher must not have resided or carried out his/her main activity (work
-
Leticia Hosta-Rigau at DTU Health Tech. The group works across materials science, organic/polymer chemistry, and molecular and cell biology. Our focus areas include drug delivery, cell mimicry, and tissue
-
Leticia Hosta-Rigau at DTU Health Tech. The group works across materials science, organic/polymer chemistry, and molecular and cell biology. Our focus areas include drug delivery, cell mimicry, and tissue
-
shape our research activities on acoustic and terrestrial communication for IoT and IoUT systems led by Assistant Professor Charalampos Orfanidis and Associate Professor Matthias Bo Stuart. In the CETP
-
towards better cardiometabolic health. Through collaborative interdisciplinary research from single-cell genomics to whole-body systems, CBMR aims to transform the basic understanding of cardiometabolic
-
Two postdoc positions on the ecology and physiology of microbial key players exposed to oxygen de...
and energetic constrains ammonia-oxidizing and methane-oxidizing microbes exhibit under oxygen depletion (and while producing oxygen) including single cell activity assays. Applicants should have a PhD
-
to produce milk protein, and your overall focus will be research in the field of cellular agriculture/precision fermentation and within this framework you will focus on genetically engineered bacterial cell
-
):eadn1640; EMBO Mol Medicine, 2024, Apr; 16(4):823-853; Nature Communications, 2024, in press; npj Precision Oncology, 2024, Mar 12;8(1):64; Nature Cell Biology, 2022, 24, 1265–1277; Genes & Development
-
, Oct 4; 23(4):557; Nature Communications, 2017 Nov 15;8(1):1523; The EMBO Journal, 2016 Jan 4;35(1):24-45; J Cell Science, 2015 Dec 1;128(23):4380-94; The EMBO Journal, 2015 Aug 13;34(16):2162-81; Genome
-
guidance within the field tumor-immunology and cell therapy. The position focuses on in vivo reprogramming of immune cells using chimeric antigen receptor (CAR) constructs against glioblastoma. The position